Invex Therapeutics (ASX:IXC) PB Ratio : 0.97 (As of Dec. 15, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Invex Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-15), Invex Therapeutics's share price is A$0.074. Invex Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.08. Hence, Invex Therapeutics's PB Ratio of today is 0.97.

The historical rank and industry rank for Invex Therapeutics's PB Ratio or its related term are showing as below:

ASX:IXC' s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 2.23
Current: 0.97

During the past 5 years, Invex Therapeutics's highest PB Ratio was 2.23. The lowest was 0.00. And the median was 0.00.

ASX:IXC's PB Ratio is ranked better than
80.87% of 1281 companies
in the Biotechnology industry
Industry Median: 2.48 vs ASX:IXC: 0.97

During the past 12 months, Invex Therapeutics's average Book Value Per Share Growth Rate was -73.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -43.70% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Invex Therapeutics was -7.90% per year. The lowest was -43.70% per year. And the median was -25.80% per year.

Back to Basics: PB Ratio

Invex Therapeutics PB Ratio Historical Data

The historical data trend for Invex Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invex Therapeutics PB Ratio Chart

Invex Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

PB Ratio

3.59

1.48

1.31

0.71

0.79

Invex Therapeutics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
PB Ratio	Get a 7-Day Free Trial					1.31	1.66	0.71	1.16	0.79

Competitive Comparison of Invex Therapeutics's PB Ratio

For the Biotechnology subindustry, Invex Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invex Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Invex Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Invex Therapeutics's PB Ratio falls into.

Invex Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Invex Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	0.074	/	0.076
	=	0.97

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Invex Therapeutics (ASX:IXC) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Invex Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Invex Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Invex Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invex Therapeutics Ltd (ASX:IXC) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

38 Rowland Street, Level 1, Subiaco, WA, AUS, 6008

Website

https://www.invextherapeutics.com

Invex Therapeutics Ltd is a biopharmaceutical company, focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised ICP including TBI, stroke and hydrocephalus. In addition, the Group has generated early-stage data on the use of Exenatide in the treatment of glaucoma, through the lowering of intraocular pressure in the eye. Geographically, it operates only in Australia.